Tribikram S. Panda

NALCO Square
Bhubaneshwar, OR, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

"Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation" - A Cross-Sectional Comparative Study.

"Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation" - A Cross-Sectional Comparative Study.

Journal: Hemoglobin

Published: April 07, 2026

Live biotherapeutics in cancer therapy.

Live biotherapeutics in cancer therapy.

Journal: Progress in molecular biology and translational science

Published: February 19, 2026

Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study.

Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study.

Journal: Leukemia research

Published: December 19, 2025

Beyond the Usual Suspects: Unexplained Childhood Hemolytic Anemia with Myopathy Unveiling as Glycogen Storage Disease Type XII.

Beyond the Usual Suspects: Unexplained Childhood Hemolytic Anemia with Myopathy Unveiling as Glycogen Storage Disease Type XII.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 07, 2025

Beyond the Usual Suspects: Unexplained Childhood Hemolytic Anemia with Myopathy Unveiled as Glycogen Storage Disease Type XII

Beyond the Usual Suspects: Unexplained Childhood Hemolytic Anemia with Myopathy Unveiled as Glycogen Storage Disease Type XII

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 07, 2025

Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia.

Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia.

Journal: The Journal of biological chemistry

Published: August 13, 2025

Experience with Anthracycline Free Intensive Regimen BE_CODD for Managing a Case of Advanced Classical Hodgkin Lymphoma (CHL).

Experience with Anthracycline Free Intensive Regimen BE_CODD for Managing a Case of Advanced Classical Hodgkin Lymphoma (CHL).

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: April 18, 2025

Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.

Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.

Journal: Hemoglobin

Published: March 04, 2025

Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India.

Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India.

Journal: Annals of hematology

Published: January 21, 2025

ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.

ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.

Journal: Hemoglobin

Published: September 05, 2024

Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience.

Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 17, 2024

Anti-donor antibody neutralization by donor type red cell challenge: A novel therapeutic strategy in refractory post-transplant pure red cell aplasia.

Anti-donor antibody neutralization by donor type red cell challenge: A novel therapeutic strategy in refractory post-transplant pure red cell aplasia.

Journal: Transfusion

Published: March 26, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026